Re: Finasteride Reduces the Risk of Bladder Cancer in a Large Prospective Screening Study
作者： Morgan Rouprêt
DOI: 10.1016/J.EURURO.2015.12.023
关键词: Screening study 、 Prospective cohort study 、 Bladder cancer 、 Urology 、 Oncology 、 Internal medicine 、 Medicine 、 Finasteride
摘要:
elsevier.com
sci-hub.se 参考文章(5)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson, Looking Back at PCPT: Looking Forward to New Paradigms in Prostate Cancer Screening and Prevention European Urology. ,vol. 51, pp. 27- 33 ,(2007) , 10.1016/J.EURURO.2006.09.002
Neil E Fleshner, M Scott Lucia, Blair Egerdie, Lorne Aaron, Gregg Eure, Indrani Nandy, Libby Black, Roger S Rittmaster, Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial The Lancet. ,vol. 379, pp. 1103- 1111 ,(2012) , 10.1016/S0140-6736(11)61619-X
Jong-Wei Hsu, Iawen Hsu, Defeng Xu, Hiroshi Miyamoto, Liang Liang, Xue-Ru Wu, Chih-Rong Shyr, Chawnshang Chang, Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor The American Journal of Pathology. ,vol. 182, pp. 1811- 1820 ,(2013) , 10.1016/J.AJPATH.2013.01.018
Olivier Cussenot, Eva Comperat, Marc-Olivier Bitker, Morgan Rouprêt, From Active Surveillance to the Concept of Secondary Prevention European Urology. ,vol. 59, pp. 568- 571 ,(2011) , 10.1016/J.EURURO.2011.01.040
Rittmaster RS Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, None, Effect of dutasteride on the risk of prostate cancer. The New England Journal of Medicine. ,vol. 362, pp. 1192- 1202 ,(2010) , 10.1056/NEJMOA0908127